Document is current
Any future updates will be listed below
-
Authors
Kucinski, Aaron
Sarter, Martin https://orcid.org/0000-0003-0441-9936
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (P50NS091856)
- License Information
-
More Information
Article History
Received: 27 October 2020
Accepted: 8 March 2021
First Online: 18 March 2021
Declarations
: The research described in this manuscript was supported by NIH grant P50NS091856 (Morris K. Udall Center for Excellence in Parkinson’s Disease Research). TAK-071 was obtained from Takeda Pharmaceutical Company. Dr. Sarter previously received compensation as a consultant for Takeda (2017-2019). No such consulting activity took place during the period this research was conducted (2020).
: The authors declare no competing interests.
